Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Gaëtane Simon"'
Autor:
Antoine Vasseur, Matthieu Carton, Severine Guiu, Paule Augereau, Lionel Uwer, Marie-Ange Mouret-Reynier, Christelle Levy, Jean-Christophe Eymard, Jean-Marc Ferrero, Marianne Leheurteur, Anthony Goncalves, Marie Robert, Thibault De La Motte Rouge, Thomas Bachelot, Thierry Petit, Marc Debled, Thomas Grinda, Isabelle Desmoulins, Laurence Vanlemmens, Vincent Nicolaï, Gaëtane Simon, Luc Cabel
Publikováno v:
Breast, Vol 65, Iss , Pp 136-144 (2022)
Background: Taxanes are one of the most effective chemotherapies (CT) in breast cancer (BC), but the efficacy of taxanes rechallenge in early metastatic relapse has been poorly studied in patients previously treated by taxanes in the (neo)adjuvant se
Externí odkaz:
https://doaj.org/article/3e5e3d1b6d254f9091fd5376422aa2e4
Autor:
Marion Bertho, Julien Fraisse, Anne Patsouris, Paul Cottu, Monica Arnedos, David Pérol, Anne Jaffré, Anthony Goncalves, Marie-Paule Lebitasy, Véronique D’Hondt, Florence Dalenc, Jean-Marc Ferrero, Christelle Levy, Sandrine Dabakuyo, Roman Rouzier, Frédérique Penault-Llorca, Lionel Uwer, Jean-Christophe Eymard, Mathias Breton, Michaël Chevrot, Sébastien Thureau, Thierry Petit, Gaëtane Simon, Jean-Sébastien Frénel
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Bone-only (BO) metastatic breast cancer (MBC) is considered a more favorable entity than other MBC presentations. However, only few retrospective series and data from selected randomized controlled trials have been reported so far. Method
Externí odkaz:
https://doaj.org/article/e5b9bcf3684642038d8891a42d6e9907
Autor:
Tina Lamy, Bastien Cabarrou, David Planchard, Xavier Quantin, Sophie Schneider, Michael Bringuier, Benjamin Besse, Nicolas Girard, Christos Chouaid, Thomas Filleron, Gaëtane Simon, Capucine Baldini
Publikováno v:
Cancers, Vol 14, Iss 1, p 92 (2021)
Background: Genomic and immunologic tumor biomarker testing has dramatically changed the prognosis of patients, particularly those treated for advanced/metastatic non-squamous non-small-cell lung cancer (aNSCLC) when access to targeted agents is avai
Externí odkaz:
https://doaj.org/article/87047e9785614b64afb65b5d8f2ae745
Autor:
Nicolas Girard, Gaëtane Simon, Maurice Pérol, Thomas Filleron, Christos Chouaid, Roland Schott, Matthieu Carton, Clarisse Audigier Valette, Mathieu Robain, Xavier Quantin, Didier Debieuvre, Radj Gervais, Hervé Lena, Bruno Coudert
Publikováno v:
Lung Cancer. 162:119-127
Background Cisplatin-based chemotherapy administered concurrently to thoracic radiation therapy is the recommended treatment for fit patients with unresectable stage III NSCLC. The aim of this study was to describe patient profiles and clinical outco
Autor:
Nicolas Girard, Eric Pichon, David Planchard, Didier Debieuvre, Radj Gervais, Gaëlle Chenuc, Pascale Dubray-Longeras, J. Otto, Eric Dansin, Hervé Lena, Anne Madroszyk, Maurice Pérol, Thomas Filleron, Xavier Quantin, Lise Bosquet, Gaëtane Simon, Coureche Kaderbhai, Sophie Cousin, Sandrine Hiret, Christelle Clément-Duchêne, Christos Chouaid, Roland Schott
Publikováno v:
Targeted Oncology. 16:801-811
In Europe, few data regarding the characteristics of EGFR exon 20 insertion (20ins) mutations in non-small cell lung cancer (NSCLC) are available. Using a large real-world cohort, we assessed the incidence, characteristics, and outcomes of patients w
Autor:
Clarisse Audigier Valette, Thomas Filleron, Didier Debieuvre, Hervé Lena, Maurice Perol, Christos Chouaid, Gaëtane Simon, Xavier Quantin, Nicolas Girard
Publikováno v:
Respiratory Medicine and Research. :101012
Autor:
Michael Bringuier, Matthieu Carton, Didier Debieuvre, David Pasquier, Maurice Perol, Thomas Filleron, Herve Léna, Xavier Quantin, Gaëtane Simon, Capucine Baldini
Publikováno v:
Journal of Geriatric Oncology. 14:101423
Autor:
Audrey Mailliez, Suzette Delaloge, Marie-Ange Mouret-Reynier, Jean-Marc Ferrero, Gaëtane Simon, Jean-Sebastien Frenel, Amélie Lusque, Thibault De La Motte Rouge, Laurence Gladieff, Olivier Caron, Thierry Petit, A. Gonçalves, Luc Cabel, Jean-Christophe Eymard, Marc Debled, Véronique D'Hondt
Publikováno v:
Cancer Research. 81:PD10-08
BACKGROUND: Approximately 5% of breast cancer (BC) patients (pts) carry a deleterious germline BRCA mutation (gBRCAm). Retrospective studies suggest that overall survival (OS) is equivalent between gBRCAm carriers and non-carriers with metastatic BC
Autor:
Jean-François Honart, Elvire Pons-Tostivint, Thierry Petit, Clémentine Jankowski, Sophie Guillermet, Amélie Lusque, Gaëtane Simon, Marc Debled, Jean-Marc Ferrero, Thomas Bachelot, Audrey Mailliez, Marian Gutowski, Léa Leufflen, Brigitte De La Lande, Nicolas Pouget, Mario Campone, Marianne Leheurteur, Jean-Christophe Eymard, Olivier Villacroux, Frédéric Marchal, Anthony Gonçalves, Jean-Sebastien Frenel, Judicaël Hotton, Christelle Levy
Publikováno v:
Annals of Surgery. 277:e153-e161
OBJECTIVE The aim was to evaluate the impact of local surgery performed during the year following metastatic breast cancer (MBC) diagnosis on patients' outcomes from a large real-life cohort. SUMMARY BACKGROUND DATA Locoregional treatment for patient
Autor:
Esnault, Cyril, Barbet, Vanessa, Filleron, Thomas, Chenuc, Gaëlle, Pérol, Maurice, Debieuvre, Didier, Girard, Nicolas, Quantin, Xavier, Thokagevistk, Katia, Gaëtane Simon, Baschet, Louise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afd9bf049a3089ab76ef852f2e17d2ad